Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cancer Drug Targets
  4. Fast Track Articles
  5. Fast Track Article
image of Recent Update on Nanoparticles Based Approaches for Management of Cancer: Wave from Traditional to Advanced Technology

Abstract

Cancer is the second most common cause of death worldwide and one of the biggest public health issues arising day by day. Cancer treatment has experienced significant progressions in recent years, as emerging technologies have provided innovative strategies to combat this intricate ailment. Among these developments, nanotechnology has shown itself to be a potentially useful tool in the fight against cancer. In the last few years, there have been several researches performed in the field of nanoparticles because of their several advantages as compared to conventional drug delivery using nanoparticles along with updating technologies like artificial intelligence (AI). The use of nanoparticles decreases the chance of undesirable side effects and shows its action on the targeted site with the help of designed carriers.AI based nanoparticles can’t only be used for achieving the targeted site of action but can also help us in advanced imaging, drug release and optimizing the drug delivery in a more customized way, which opens the door of a new era for tailored made medicine.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccdt/10.2174/0115680096323618240911140624
2024-10-25
2025-04-12

  • From This Site

    /content/journals/ccdt/10.2174/0115680096323618240911140624
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Lee B.K. Yun Y.H. Park K. Smart nanoparticles for drug delivery: Boundaries and opportunities. Chem. Eng. Sci. 2015 125 158 164 10.1016/j.ces.2014.06.042 25684780
    [Google Scholar]
  2. Chowdhury S. Yusof F. Salim W.W.A.W. Sulaiman N. Faruck M.O. An overview of drug delivery vehicles for cancer treatment: Nanocarriers and nanoparticles including photovoltaic nanoparticles. J. Photochem. Photobiol. B 2016 164 151 159 10.1016/j.jphotobiol.2016.09.013 27683958
    [Google Scholar]
  3. Hooshyar S.P. Panahi H.A. Moniri E. Farsadrooh M. Tailoring a new hyperbranched PEGylated dendrimer nano-polymer as a super-adsorbent for magnetic solid-phase extraction and determination of letrozole in biological and pharmaceutical samples. J. Mol. Liq. 2021 338 116772 10.1016/j.molliq.2021.116772
    [Google Scholar]
  4. Kumar B. Jalodia K. Kumar P. Gautam H.K. Recent advances in nanoparticle-mediated drug delivery. J. Drug Deliv. Sci. Technol. 2017 41 260 268 10.1016/j.jddst.2017.07.019
    [Google Scholar]
  5. Zheng X. Zhang C. Guo Q. Wan X. Shao X. Liu Q. Zhang Q. Dual-functional nanoparticles for precise drug delivery to Alzheimer’s disease lesions: Targeting mechanisms, pharmacodynamics and safety. Int. J. Pharm. 2017 525 1 237 248 10.1016/j.ijpharm.2017.04.033 28432017
    [Google Scholar]
  6. Peer D. Karp J. M. Hong S. Farokhzad O. C. Margalit R. Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007 2 12 751 60 10.1038/nnano.2007.387
    [Google Scholar]
  7. Siegel R.L. Miller K.D. Wagle N.S. Jemal A. Cancer statistics, 2023. CA Cancer J. Clin. 2023 73 1 17 48 10.3322/caac.21763 36633525
    [Google Scholar]
  8. Mathur P. Sathishkumar K. Chaturvedi M. Das P. Stephen S. Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. Indian J. Med. Res. 2022 156 4 598 607 10.4103/ijmr.ijmr_1821_22 36510887
    [Google Scholar]
  9. Siddiqui M.A. Akhter J. Aarzoo Junaid Bashir D. Manzoor S. Rastogi S. Arora I. Aggarwal N.B. Samim M. Resveratrol loaded nanoparticles attenuate cognitive impairment and inflammatory markers in PTZ-induced kindled mice. Int. Immunopharmacol. 2021 101 108287 10.1016/j.intimp.2021.108287 34731689
    [Google Scholar]
  10. Kumari D. Perveen S. Sharma R. Singh K. Advancement in leishmaniasis diagnosis and therapeutics: An update. Eur. J. Pharmacol. 2021 910 174436 10.1016/j.ejphar.2021.174436 34428435
    [Google Scholar]
  11. Mitchell M. J. Billingsley M. M. Haley R. M. Wechsler M. E. Peppas N. A. Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 2021 20 2 101 124 10.1038/s41573‑020‑0090‑8
    [Google Scholar]
  12. Liu Y. Li K. Liu B. Feng S.S. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials 2010 31 35 9145 9155 10.1016/j.biomaterials.2010.08.053 20864169
    [Google Scholar]
  13. Demirci U. Coşkun U. Göçün P.U. Gurlek B. Saka B. Öztürk B. Benekli M. Büyükberber S. Four different malignancies in one patient: A case report. Cases J. 2010 3 1 53 10.1186/1757‑1626‑3‑53 20205852
    [Google Scholar]
  14. Dobruch J. Oszczudłowski M. Bladder cancer: Current challenges and future directions. Medicina (Kaunas) 2021 57 8 749 10.3390/medicina57080749 34440955
    [Google Scholar]
  15. Charlton M.E. Adamo M.P. Sun L. Deorah S. Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: A review of SEER data, 2004‐2010. Cancer 2014 120 S23 3815 3825 10.1002/cncr.29047 25412393
    [Google Scholar]
  16. Feng Y. Spezia M. Huang S. Yuan C. Zeng Z. Zhang L. Ji X. Liu W. Huang B. Luo W. Liu B. Lei Y. Du S. Vuppalapati A. Luu H.H. Haydon R.C. He T.C. Ren G. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018 5 2 77 106 10.1016/j.gendis.2018.05.001 30258937
    [Google Scholar]
  17. Ataollahi M. R. Sharifi J. Paknahad M. R. Paknahad A. Breast cancer and associated factors: A review. J Med Life 2015 8 6 11 28316699
    [Google Scholar]
  18. Knowlton C.A. Mackay M.K. Speer T.W. Vera R.B. Arthur D.W. Wazer D.E. Lanciano R. Brashears J.H. Knowlton C.A. Mackay M.K. Troicki F.T. Poli J. Yaeger T.E. Yaeger T.E. Mose S. Troicki F.T. Poli J. Dragun A.E. Rengan R. Thomas C.R. Donahue B.R. Cooper J.S. Speer T.W. Troicki F.T. Poli J. Speer T.W. Guerrieri P. Montemaggi P. Nieder C. Speer T.W. Christodouleas J.P. Oliai C. Yaeger T.E. Heese C. Perez C.A. Thorstad W.L. Michalski D. Huq M.S. Knowlton C.A. Mackay M.K. Fisher B.J. Limbergen E. Choo B.A. Lu J.J. Brady L.W. Fisher B.J. Daugherty L.C. Rübe C. Yeung D. Palta J. Huth B.J. Dragun A.E. Huth B.J. Huth B.J. Rübe C.E. Reiff J.E. Yaeger T.E. Yaeger T.E. Speer T.W. Dragun A.E. Nieder C. Troicki F.T. Poli J. Budach V. Gracely E.J. Holmes T. Scanderbeg D.J. Christodouleas J.P. Holmes T. Fisher B.J. Daugherty L.C. Speer T.W. Classen J. Mose S. Heese C. Laramore G.E. Liao J.J. Rockhill J.K. Rübe C. Cancer Colon. Encycl. Radiat. Oncol. 2013 Jun 77 77 10.1007/978‑3‑540‑85516‑3_1047
    [Google Scholar]
  19. Luo C. Cen S. Ding G. Wu W. Mucinous colorectal adenocarcinoma: Clinical pathology and treatment options. Cancer Commun. (Lond.) 2019 39 1 1 13 10.1186/s40880‑019‑0361‑0 30922401
    [Google Scholar]
  20. Oh J.H. Jun D.W. The latest global burden of liver cancer: A past and present threat. Clin. Mol. Hepatol. 2023 29 2 355 357 10.3350/cmh.2023.0070 36891606
    [Google Scholar]
  21. Philips C.A. Rajesh S. Nair D.C. Ahamed R. Abduljaleel J.K. Augustine P. Hepatocellular carcinoma in 2021: An exhaustive update. Cureus 2021 13 11 e19274 10.7759/cureus.19274 34754704
    [Google Scholar]
  22. Chidambaranathan-Reghupaty S. Fisher P.B. Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv. Cancer Res. 2021 149 1 61 10.1016/bs.acr.2020.10.001 33579421
    [Google Scholar]
  23. Siddiqui F. Vaqar S. Siddiqui A. H. Lung Cancer StatPearls Publishing 2023 29493979
    [Google Scholar]
  24. Purandare N.C. Rangarajan V. Imaging of lung cancer: Implications on staging and management. Indian J. Radiol. Imaging 2015 25 2 109 120 10.4103/0971‑3026.155831 25969634
    [Google Scholar]
  25. Threlfall T. Wittorff J. Boutdara P. Heyworth J. Katris P. Sheiner H. Fritschi L. Collection of population-based cancer staging information in Western Australia – A feasibility study. Popul. Health Metr. 2005 3 1 9 10.1186/1478‑7954‑3‑9 16105180
    [Google Scholar]
  26. Chennamadhavuni A. Lyengar V. Mukkamalla SKR. Shimanovsky A. Leukemia 2023 StatPearls Publishing 32809325
    [Google Scholar]
  27. Shanbhag S. Ambinder R.F. Hodgkin lymphoma: A review and update on recent progress. CA Cancer J. Clin. 2018 68 2 116 132 10.3322/caac.21438 29194581
    [Google Scholar]
  28. Hernández-Blanquisett A. Quintero-Carreño V. Martínez-Ávila M.C. Porto M. Manzur-Barbur M.C. Buendía E. Metastatic pancreatic cancer: Where are we? Oncol. Rev. 2024 17 11364 10.3389/or.2023.11364 38304752
    [Google Scholar]
  29. Lambert A.W. Pattabiraman D.R. Weinberg R.A. Emerging biological principles of metastasis. Cell 2017 168 4 670 691 10.1016/j.cell.2016.11.037 28187288
    [Google Scholar]
  30. Chakraborty S. Rahman T. The difficulties in cancer treatment. Ecancermedicalscience 2012 6 ed16 10.3332/ECANCER.2012.ED16 24883085
    [Google Scholar]
  31. Ramamoorthy A. Janardhanan S. Jeevakarunyam S. Jeddy N. Eagappan S. Integrative oncology in Indian subcontinent: An overview. J. Clin. Diagn. Res. 2015 9 3 XE01 XE03 10.7860/JCDR/2015/12185.5714 25954692
    [Google Scholar]
  32. Latte-Naor S. Mao J.J. Putting integrative oncology into practice: Concepts and approaches. J. Oncol. Pract. 2019 15 1 7 14 10.1200/JOP.18.00554 30629900
    [Google Scholar]
  33. Mosleh-Shirazi S. Abbasi M. Moaddeli M. Vaez A. Shafiee M. Kasaee S.R. Amani A.M. Hatam S. Nanotechnology advances in the detection and treatment of cancer: An overview. Nanotheranostics 2022 6 4 400 423 10.7150/ntno.74613 36051855
    [Google Scholar]
  34. Din F. Aman W. Ullah I. Qureshi O.S. Mustapha O. Shafique S. Zeb A. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int. J. Nanomedicine 2017 12 7291 7309 10.2147/IJN.S146315 29042776
    [Google Scholar]
  35. Cheng X. Xie Q. Sun Y. Advances in nanomaterial-based targeted drug delivery systems. Front. Bioeng. Biotechnol. 2023 11 1177151 10.3389/fbioe.2023.1177151 37122851
    [Google Scholar]
  36. Shams M. Abdallah S. Alsadoun L. Hamid Y.H. Gasim R. Hassan A. Oncological horizons: The synergy of medical and surgical innovations in cancer treatment. Cureus 2023 15 11 e49249 10.7759/cureus.49249 38143618
    [Google Scholar]
  37. Davis J.L. Murray J.F. History and physical examination. Murray Nadel’s Textb. Respir. Med. 2016 1 263 277.e2 10.1016/B978‑1‑4557‑3383‑5.00016‑6
    [Google Scholar]
  38. Lewandowska A. Rudzki G. Lewandowski T. Rudzki S. The problems and needs of patients diagnosed with cancer and their caregivers. Int. J. Environ. Res. Public Health 2020 18 1 87 10.3390/ijerph18010087 33374440
    [Google Scholar]
  39. Maxim L.D. Niebo R. Utell M.J. Screening tests: A review with examples. Inhal. Toxicol. 2014 26 13 811 828 10.3109/08958378.2014.955932 25264934
    [Google Scholar]
  40. Mohseni S. Shojaiefard A. Khorgami Z. Alinejad S. Ghorbani A. Ghafouri A. Peripheral lymphadenopathy: Approach and diagnostic tools. Iran J Med Sci 2014 39 158 70 24753638
    [Google Scholar]
  41. DeCou J. Nagalli S. Lymphadenopathy. Pediatr. Surg. Diagnosis Treat. 2022 Aug 621 627 10.1007/978‑3‑030‑96542‑6_55 32644344
    [Google Scholar]
  42. Gautam D. Talwan P. Singh R. Kumar S. Joshi G. Nanotechnological carriers in the treatment of cancer: A review. Curr. Nanomed. 2023 13 10.2174/0124681873270774231008100554
    [Google Scholar]
  43. Fass L. Imaging and cancer: A review. Mol. Oncol. 2008 2 2 115 152 10.1016/j.molonc.2008.04.001 19383333
    [Google Scholar]
  44. Kang H. Lee H.Y. Lee K.S. Kim J.H. Imaging-based tumor treatment response evaluation: Review of conventional, new, and emerging concepts. Korean J. Radiol. 2012 13 4 371 390 10.3348/kjr.2012.13.4.371 22778559
    [Google Scholar]
  45. Kumar R. Srivastava R. Srivastava S. Detection and classification of cancer from microscopic biopsy images using clinically significant and biologically interpretable features. J. Med. Eng. 2015 2015 1 14 10.1155/2015/457906 27006938
    [Google Scholar]
  46. Kasraeian S. Allison D.C. Ahlmann E.R. Fedenko A.N. Menendez L.R. A comparison of fine-needle aspiration, core biopsy, and surgical biopsy in the diagnosis of extremity soft tissue masses. Clin. Orthop. Relat. Res. 2010 468 11 2992 3002 10.1007/s11999‑010‑1401‑x 20512437
    [Google Scholar]
  47. Łukasiewicz E. Ziemiecka A. Jakubowski W. Vojinovic J. Bogucevska M. Dobruch-Sobczak K. Fine-needle versus core-needle biopsy – Which one to choose in preoperative assessment of focal lesions in the breasts? Literature review. J. Ultrason. 2017 17 71 267 274 10.15557/JoU.2017.0039 29375902
    [Google Scholar]
  48. Sarhadi V.K. Armengol G. Molecular biomarkers in cancer. Biomolecules 2022 12 8 1021 10.3390/biom12081021 35892331
    [Google Scholar]
  49. Singh S. Nagpal M. Singh P. Chauhan P. Zaidi M. Tumor markers: A diagnostic tool. Natl. J. Maxillofac. Surg. 2016 7 1 17 20 10.4103/0975‑5950.196135 28163473
    [Google Scholar]
  50. Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian J. Med. Paediatr. Oncol. 2009 30 1 1 8 10.4103/0971‑5851.56328 20668599
    [Google Scholar]
  51. Farjadian F. Ghasemi A. Gohari O. Roointan A. Karimi M. Hamblin M.R. Nanopharmaceuticals and nanomedicines currently on the market: Challenges and opportunities. Nanomedicine (Lond.) 2019 14 1 93 126 10.2217/nnm‑2018‑0120 30451076
    [Google Scholar]
  52. Sultana A. Zare M. Thomas V. Kumar T.S.S. Ramakrishna S. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects. Medicine in Drug Discovery 2022 15 100134 10.1016/j.medidd.2022.100134
    [Google Scholar]
  53. Baranwal J. Barse B. Di Petrillo A. Gatto G. Pilia L. Kumar A. Nanoparticles in cancer diagnosis and treatment. Materials (Basel) 2023 16 15 5354 10.3390/ma16155354 37570057
    [Google Scholar]
  54. Ghazal H. Waqar A. Yaseen F. Shahid M. Sultana M. Tariq M. Bashir M.K. Tahseen H. Raza T. Ahmad F. Role of nanoparticles in enhancing chemotherapy efficacy for cancer treatment. Next Materials 2024 2 100128 10.1016/j.nxmate.2024.100128
    [Google Scholar]
  55. Rahman M. Magnetic resonance imaging and iron-oxide nanoparticles in the era of personalized medicine. Nanotheranostics 2023 7 4 424 449 10.7150/ntno.86467 37650011
    [Google Scholar]
  56. Yang Y. Zheng X. Chen L. Gong X. Yang H. Duan X. Zhu Y. Multifunctional gold nanoparticles in cancer diagnosis and treatment. Int. J. Nanomedicine 2022 17 2041 2067 10.2147/IJN.S355142 35571258
    [Google Scholar]
  57. Lim Z. Z. J. Li J. E. J. Ng C. T. Yung L. Y. L. Bay B. H. Gold nanoparticles in cancer therapy. Acta Pharmacol Sin. 2011 32 8 983 90 10.1038/aps.2011.82
    [Google Scholar]
  58. Ravanshad R. Karimi Zadeh A. Amani A.M. Mousavi S.M. Hashemi S.A. Savar Dashtaki A. Mirzaei E. Zare B. Application of nanoparticles in cancer detection by Raman scattering based techniques. Nano Rev. Exp. 2018 9 1 1373551 10.1080/20022727.2017.1373551 30410710
    [Google Scholar]
  59. Devi S. Kumar M. Tiwari A. Tiwari V. Kaushik D. Verma R. Bhatt S. Sahoo B.M. Bhattacharya T. Alshehri S. Ghoneim M.M. Babalghith A.O. Batiha G.E-S. Quantum dots: An emerging approach for cancer therapy. Front. Mater. 2022 8 798440 10.3389/fmats.2021.798440
    [Google Scholar]
  60. Fang M. Peng C.W. Pang D.W. Li Y. Quantum dots for cancer research: Current status, remaining issues, and future perspectives. Cancer Biol. Med. 2012 9 3 151 163 10.7497/J.ISSN.2095‑3941.2012.03.001 23691472
    [Google Scholar]
  61. Dirheimer L. Pons T. Marchal F. Bezdetnaya L. Quantum dots mediated imaging and phototherapy in cancer spheroid models: State of the art and perspectives. Pharmaceutics 2022 14 10 2136 10.3390/pharmaceutics14102136 36297571
    [Google Scholar]
  62. Wang S. Chen Y. Guo J. Huang Q. Liposomes for tumor targeted therapy: A review. Int. J. Mol. Sci. 2023 24 3 2643 10.3390/ijms24032643 36768966
    [Google Scholar]
  63. Akbarzadeh A. Rezaei-Sadabady R. Davaran S. Joo S.W. Zarghami N. Hanifehpour Y. Samiei M. Kouhi M. Nejati-Koshki K. Liposome: Classification, preparation, and applications. Nanoscale Res. Lett. 2013 8 1 102 10.1186/1556‑276X‑8‑102 23432972
    [Google Scholar]
  64. Zhao Y. Ren W. Zhong T. Zhang S. Huang D. Guo Y. Yao X. Wang C. Zhang W.Q. Zhang X. Zhang Q. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. J. Control. Release 2016 222 56 66 10.1016/j.jconrel.2015.12.006 26682502
    [Google Scholar]
  65. Zhang J.A. Anyarambhatla G. Ma L. Ugwu S. Xuan T. Sardone T. Ahmad I. Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur. J. Pharm. Biopharm. 2005 59 1 177 187 10.1016/j.ejpb.2004.06.009 15567316
    [Google Scholar]
  66. Sánchez-López E. Gomes D. Esteruelas G. Bonilla L. Lopez-Machado A.L. Galindo R. Cano A. Espina M. Ettcheto M. Camins A. Silva A.M. Durazzo A. Santini A. Garcia M.L. Souto E.B. Metal-based nanoparticles as antimicrobial agents: An overview. Nanomaterials (Basel) 2020 10 2 292 10.3390/nano10020292 32050443
    [Google Scholar]
  67. Yan X. Chang Y. Zhao W. Qian C. Yin X. Fan X. Zhu X. Zhao X. Ma X.F. Transcriptome profiling reveals that foliar water uptake occurs with C3 and crassulacean acid metabolism facultative photosynthesis in Tamarix ramosissima under extreme drought. AoB Plants 2022 14 1 plab060 10.1093/aobpla/plab060 35047161
    [Google Scholar]
  68. Anbazhagan R. Muthusamy G. Krishnamoorthi R. Kumaresan S. Rajendra Prasad N. Lai J.Y. Yang J.M. Tsai H.C. PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P‐glycoprotein‐mediated multidrug resistance. Biotechnol. Bioeng. 2021 118 3 1213 1223 10.1002/bit.27645 33289076
    [Google Scholar]
  69. Gagliardi A. Giuliano E. Venkateswararao E. Fresta M. Bulotta S. Awasthi V. Cosco D. Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front. Pharmacol. 2021 12 601626 10.3389/fphar.2021.601626 33613290
    [Google Scholar]
  70. Xiao X. Teng F. Shi C. Chen J. Wu S. Wang B. Meng X. Essiet Imeh A. Li W. Polymeric nanoparticles—Promising carriers for cancer therapy. Front. Bioeng. Biotechnol. 2022 10 1024143 10.3389/fbioe.2022.1024143 36277396
    [Google Scholar]
  71. Chehelgerdi M. Chehelgerdi M. Allela O.Q.B. Pecho R.D.C. Jayasankar N. Rao D.P. Thamaraikani T. Vasanthan M. Viktor P. Lakshmaiya N. Saadh M.J. Amajd A. Abo-Zaid M.A. Castillo-Acobo R.Y. Ismail A.H. Amin A.H. Akhavan-Sigari R. Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation. Mol. Cancer 2023 22 1 169 10.1186/s12943‑023‑01865‑0 37814270
    [Google Scholar]
  72. Sivadasan D. Ramakrishnan K. Mahendran J. Ranganathan H. Karuppaiah A. Rahman H. Solid lipid nanoparticles: Applications and prospects in cancer treatment. Int. J. Mol. Sci. 2023 24 7 6199 10.3390/ijms24076199 37047172
    [Google Scholar]
  73. Khan M.Z. Tahir D. Asim M. Israr M. Haider A. Xu D.D. Revolutionizing cancer care: Advances in carbon-based materials for diagnosis and treatment. Cureus 2024 16 1 e52511 10.7759/cureus.52511 38371088
    [Google Scholar]
  74. Tan J.M. Bullo S. Fakurazi S. Hussein M.Z. Preparation, characterisation and biological evaluation of biopolymer-coated multi-walled carbon nanotubes for sustained-delivery of silibinin. Sci. Rep. 2020 10 1 16941 10.1038/s41598‑020‑73963‑8 33037287
    [Google Scholar]
  75. Farzin A. Etesami S.A. Quint J. Memic A. Tamayol A. Magnetic nanoparticles in cancer therapy and diagnosis. Adv. Healthc. Mater. 2020 9 9 1901058 10.1002/adhm.201901058 32196144
    [Google Scholar]
  76. Aladesuyi O.A. Oluwafemi O.S. The role of magnetic nanoparticles in cancer management. Nano-Struct. Nano-Objects 2023 36 101053 10.1016/j.nanoso.2023.101053
    [Google Scholar]
  77. Farinha P. Coelho J.M.P. Reis C.P. Gaspar M.M. A comprehensive updated review on magnetic nanoparticles in diagnostics. Nanomaterials (Basel) 2021 11 12 3432 10.3390/nano11123432 34947781
    [Google Scholar]
  78. Mahato K. Nagpal S. Shah MA. Srivastava A. Maurya PK. Roy S. Jaiswal A. Singh R. Chandra P. Gold nanoparticle surface engineering strategies and their applications in biomedicine and diagnostics. 3 Biotech 2019 9 2 57 10.1007/s13205‑019‑1577‑z
    [Google Scholar]
  79. Arvizo R. Bhattacharya R. Mukherjee P. Gold nanoparticles: Opportunities and challenges in nanomedicine. Expert Opin. Drug Deliv. 2010 7 6 753 763 10.1517/17425241003777010 20408736
    [Google Scholar]
  80. Christ G.J. Saul J.M. Furth M.E. Andersson K.E. The pharmacology of regenerative medicine. Pharmacol. Rev. 2013 65 3 1091 1133 10.1124/pr.112.007393 23818131
    [Google Scholar]
  81. Singh S. Dhawan A. Karhana S. Bhat M. Dinda A.K. Quantum dots: An emerging tool for point-of-care testing. Micromachines (Basel) 2020 11 12 1058 10.3390/mi11121058 33260478
    [Google Scholar]
  82. Liang Z. Khawar M.B. Liang J. Sun H. Bio-conjugated quantum dots for cancer research: Detection and imaging. Front. Oncol. 2021 11 749970 10.3389/fonc.2021.749970 34745974
    [Google Scholar]
  83. Peng C. Liu J. Yang G. Li Y. Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: Quantum dot-based identification of biomarkers in cancer stromal cells. Int. J. Nanomedicine 2017 13 161 174 10.2147/IJN.S143871 29343955
    [Google Scholar]
  84. Bazak R. Houri M. Achy S.E. Hussein W. Refaat T. Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Mol. Clin. Oncol. 2014 2 6 904 908 10.3892/mco.2014.356 25279172
    [Google Scholar]
  85. Subhan M.A. Yalamarty S.S.K. Filipczak N. Parveen F. Torchilin V.P. Recent advances in tumor targeting via EPR effect for cancer treatment. J. Pers. Med. 2021 11 6 571 10.3390/jpm11060571 34207137
    [Google Scholar]
  86. Bazak R. Houri M. El Achy S. Kamel S. Refaat T. Cancer active targeting by nanoparticles: A comprehensive review of literature. J. Cancer Res. Clin. Oncol. 2015 141 5 769 784 10.1007/s00432‑014‑1767‑3 25005786
    [Google Scholar]
  87. Mehrotra P. Biosensors and their applications – A review. J. Oral Biol. Craniofac. Res. 2016 6 2 153 159 10.1016/j.jobcr.2015.12.002 27195214
    [Google Scholar]
  88. Haleem A. Javaid M. Singh R.P. Suman R. Rab S. Biosensors applications in medical field: A brief review. Sensors Int 2021 2 100100 10.1016/j.sintl.2021.100100
    [Google Scholar]
  89. Quazi S. Application of biosensors in cancers, an overview. Front. Bioeng. Biotechnol. 2023 11 1193493 10.3389/fbioe.2023.1193493 37691902
    [Google Scholar]
  90. Naresh V. Lee N. A review on biosensors and recent development of nanostructured materials-enabled biosensors. Sensors (Basel) 2021 21 4 1109 10.3390/s21041109 33562639
    [Google Scholar]
  91. Mousa S. Mousa S.A. Biosensors: The new wave in cancer diagnosis. Nanotechnol. Sci. Appl. 2010 4 1 1 10 10.2147/NSA.S13465 24198482
    [Google Scholar]
  92. Das S. Devireddy R. Gartia M.R. Surface Plasmon Resonance (SPR) sensor for cancer biomarker detection. Biosensors (Basel) 2023 13 3 396 10.3390/bios13030396 36979608
    [Google Scholar]
  93. Solhi E. Hasanzadeh M. Critical role of biosensing on the efficient monitoring of cancer proteins/biomarkers using label-free aptamer based bioassay. Biomed. Pharmacother. 2020 132 110849 10.1016/j.biopha.2020.110849 33068928
    [Google Scholar]
  94. Polat E. O. Cetin MM. Tabak AF. Bilget Güven E. Uysal BÖ. Arsan T. Kabbani A. Hamed H. Gül SB. Transducer technologies for biosensors and their wearable applications. Biosensors (Basel) 2022 12 6 385 10.3390/bios12060385
    [Google Scholar]
  95. Bhalla N. Jolly P. Formisano N. Estrela P. Introduction to biosensors. Essays Biochem. 2016 60 1 1 8 10.1042/EBC20150001 27365030
    [Google Scholar]
  96. Soltani M. Moradi Kashkooli F. Souri M. Zare Harofte S. Harati T. Khadem A. Haeri Pour M. Raahemifar K. Enhancing clinical translation of cancer using nanoinformatics. Cancers (Basel) 2021 13 10 2481 10.3390/cancers13102481 34069606
    [Google Scholar]
  97. Ali K. A. Mohin S. Mondal P. Goswami S. Ghosh S. Choudhuri S. Influence of artificial intelligence in modern pharmaceutical formulation and drug development. Fut J Pharm Sci 2024 10 1 10.1186/s43094‑024‑00625‑1
    [Google Scholar]
  98. Kashyap B.K. Singh V.V. Solanki M.K. Kumar A. Ruokolainen J. Kesari K.K. Smart nanomaterials in cancer theranostics: Challenges and opportunities. ACS Omega 2023 8 16 14290 14320 10.1021/acsomega.2c07840 37125102
    [Google Scholar]
  99. Fan D. Cao Y. Cao M. Wang Y. Cao Y. Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Ther 2023 8 1 293 10.1038/s41392‑023‑01536‑y
    [Google Scholar]
  100. Das K.P. J C. Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges. Front Med Technol 2023 4 1067144 10.3389/fmedt.2022.1067144 36688144
    [Google Scholar]
  101. Vora L.K. Gholap A.D. Jetha K. Thakur R.R.S. Solanki H.K. Chavda V.P. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics 2023 15 7 1916 10.3390/pharmaceutics15071916 37514102
    [Google Scholar]
  102. Sun L. Liu H. Ye Y. Lei Y. Islam R. Tan S. Tong R. Miao Y.B. Cai L. Smart nanoparticles for cancer therapy. Signal Transduct. Target. Ther. 2023 8 1 418 10.1038/s41392‑023‑01642‑x 37919282
    [Google Scholar]
  103. Mendes B. B. Conniot J. Avital A. Yao D. Jiang X. Zhou X. Sharf-Pauker N. Xiao Y. Adir O. Liang H. Nanodelivery of nucleic acids. Nat Rev Methods Primers 2022 2 24 10.1038/s43586‑022‑00104‑y
    [Google Scholar]
  104. Sun Y. Ma X. Hu H. Application of nano-drug delivery system based on cascade technology in cancer treatment. Int. J. Mol. Sci. 2021 22 11 5698 10.3390/ijms22115698 34071794
    [Google Scholar]
  105. Toy R. Bauer L. Hoimes C. Ghaghada KB. Karathanasis E. Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev 2014 76 79 97 10.1016/j.addr.2014.08.002.
    [Google Scholar]
  106. Tiwari H. Rai N. Singh S. Gupta P. Verma A. Singh A.K. Kajal Salvi P. Singh S.K. Gautam V. Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics. Bioengineering (Basel) 2023 10 7 760 10.3390/bioengineering10070760 37508788
    [Google Scholar]
  107. Malik S. Waheed Y. Emerging applications of nanotechnology in dentistry. Dent. J. 2023 11 11 266 10.3390/dj11110266 37999030
    [Google Scholar]
  108. Egwuatu O.P. AI-enabled diagnostics and monitoring in nanomedicine review article: AI-enabled diagnostics and monitoring in nanomedicine. Eurasian J. Sci. Technol. 2024 4 March 208 229 10.48309/EJST.2024.426725.1116
    [Google Scholar]
  109. Sufyan M. Shokat Z. Ashfaq U.A. Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective. Comput. Biol. Med. 2023 165 107356 10.1016/j.compbiomed.2023.107356 37688994
    [Google Scholar]
/content/journals/ccdt/10.2174/0115680096323618240911140624
Loading
Recent Update on Nanoparticles Based Approaches for Management of Cancer: Wave from Traditional to Advanced Technology
Bentham Science Publishers ; https://doi.org/10.2174/0115680096323618240911140624
/content/journals/ccdt/10.2174/0115680096323618240911140624
/content/journals/ccdt/10.2174/0115680096323618240911140624
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Cancer treatment ; artificial intelligence ; nanoparticles ; nanomedicine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test